These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 8438465

  • 1. Immunosuppressive effects of leflunomide in a cardiac allograft model.
    Williams JW, Xiao F, Foster PF, Chong A, Sharma S, Bartlett R, Sankary HN.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):745-6. PubMed ID: 8438465
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation.
    Candinas D, Achilleos O, Lee SJ, Dalgic A, Mayer AD, Buckels JA, McMaster P, D'Silva M.
    Transplant Proc; 1994 Dec; 26(6):3251-2. PubMed ID: 7527959
    [No Abstract] [Full Text] [Related]

  • 3. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD, Gandy KL, Morris RE, Hoyt G, Gutierrez J, Reitz BA, Robbins RC.
    J Heart Lung Transplant; 1995 Dec; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts.
    Xiao F, Chong A, Foster P, Sankary H, McChesney L, Williams JM, Frieders D, Williams JW.
    Transplant Proc; 1994 Jun; 26(3):1263-5. PubMed ID: 8029902
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Oral leflunomide prevents small bowel allograft rejection in the rat.
    He G, McAlister VC, Lee TD, Bitter-Suermann H, Theal M, Wright J, MacDonald AS.
    Transplant Proc; 1994 Jun; 26(3):1613. PubMed ID: 8030057
    [No Abstract] [Full Text] [Related]

  • 9. Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model.
    Lin Y, Sobis H, Vandeputte M, Waer M.
    Transplant Proc; 1995 Feb; 27(1):305-6. PubMed ID: 7879012
    [No Abstract] [Full Text] [Related]

  • 10. Role of ICAM-1 and LFA-1 in cardiac allograft rejection of the rat.
    Komori A, Nagata M, Ochiai T, Nakajima K, Hori S, Asano T, Isono K, Tamatani T, Miyasaka M.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):831-2. PubMed ID: 8094916
    [No Abstract] [Full Text] [Related]

  • 11. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H, Takahashi M, Kaneko T, Murakami T, Hakamata Y, Kudou S, Kishi T, Fukuchi K, Iwanami S, Kuriyama K, Yasue T, Enosawa S, Matsumoto K, Takeyoshi I, Morishita Y, Kobayashi E.
    Circulation; 2005 Jan 18; 111(2):222-9. PubMed ID: 15642767
    [Abstract] [Full Text] [Related]

  • 12. Prolongation of allogeneic transplanted skin grafts and induction of tolerance by leflunomide, a new immunosuppressive isoxazol derivative.
    Schorlemmer HU, Seiler FR, Bartlett RR.
    Transplant Proc; 1993 Feb 18; 25(1 Pt 1):763-7. PubMed ID: 8438472
    [No Abstract] [Full Text] [Related]

  • 13. Complete control of humoral and cell-mediated xenoreactions with the combination of leflunomide and cyclosporine.
    Chong AS, Shen J, Xiao F, Blinder L, Foster P, Sankary H, Williams JW.
    Transplant Proc; 1996 Apr 18; 28(2):684. PubMed ID: 8623344
    [No Abstract] [Full Text] [Related]

  • 14. Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat.
    Bilolo KK, Ouyang J, Wang X, Zhu S, Jiang W, Qi S, Xu D, Hebert MJ, Bekersky I, Fitzsimmons WE, Chen H.
    Transplantation; 2003 Jun 15; 75(11):1881-7. PubMed ID: 12811249
    [Abstract] [Full Text] [Related]

  • 15. The effects of AEB071 (sotrastaurin) with tacrolimus on rat heterotopic cardiac allograft rejection and survival.
    Fang YH, Joo DJ, Lim BJ, Huh KH, Kim MS, Suh H, Kim YS.
    J Surg Res; 2011 Nov 15; 171(1):e133-7. PubMed ID: 21816421
    [Abstract] [Full Text] [Related]

  • 16. Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection?
    Deuse T, Schrepfer S, Pelletier MP, Fischbein MP, Robbins RC, Reichenspurner H.
    Transplant Proc; 2007 Mar 15; 39(2):569-72. PubMed ID: 17362784
    [Abstract] [Full Text] [Related]

  • 17. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation.
    Xiao F, Shen J, Chong A, Liu W, Foster P, Blinder HL, Sankary H, McChesney L, Mital D, Williams JW.
    Transplant Proc; 1996 Apr 15; 28(2):691-2. PubMed ID: 8623348
    [No Abstract] [Full Text] [Related]

  • 18. Brequinar sodium suppresses liver allograft rejection and induces permanent tolerance in the rat.
    Knoop M, Cramer DV, Chapman FC, Makowka L.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 1):706-7. PubMed ID: 8438447
    [No Abstract] [Full Text] [Related]

  • 19. Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M, Antoniou E, DeRoover A, Nishimura Y, Howie A, McMaster P.
    Transplant Proc; 1996 Apr 15; 28(2):930-1. PubMed ID: 8623467
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of the malononitrilamide X 920715 as compared with leflunomide in cardiac allo- and xenotransplantation in rats.
    Lin Y, Segers C, Waer M.
    Transplant Proc; 1996 Dec 15; 28(6):3036. PubMed ID: 8962178
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.